Nattala Pharmaceuticles (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -53.95%
- Profit Growth 314.86%
- Ebitda -198.28%
- Net Worth 303.63%
- Total Assets 23.23%
About Nattala Pharmaceuticles (Opc)
Nattala Pharmaceuticles (Opc) Private Limited (NPOPL) is a Company incorporated in India on 06 April 2018 (Six years and ten months 16 days old ). Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyanka Sharma serves as a director at the Company.
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999PB2018OPC047708
- Company No.
047708
- Incorporation Date
06 Apr 2018
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Nattala Pharmaceuticles (Opc) Private Limited offer?
Nattala Pharmaceuticles (Opc) Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Hand Sanitizers & Personal Hygiene, Bath Soaps, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Digestive Drugs, Common Disease Medicines, Cough Syrup, Herbal Capsules.
Who are the key members and board of directors at Nattala Pharmaceuticles (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Sharma  | Director | 06-Apr-2018 | Current |
Financial Performance of Nattala Pharmaceuticles (Opc).
Nattala Pharmaceuticles (Opc) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.95% decrease. The company also saw a substantial improvement in profitability, with a 314.86% increase in profit. The company's net worth Soared by an impressive increase of 303.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nattala Pharmaceuticles (Opc)?
Unlock access to Nattala Pharmaceuticles (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nattala Pharmaceuticles (Opc)?
Unlock and access historical data on people associated with Nattala Pharmaceuticles (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nattala Pharmaceuticles (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nattala Pharmaceuticles (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.